Projected Earnings Date: 2019-11-04    (Delayed quote data   2025-10-28)
Last
 18.08
Change
 ⇑ +0.31   (+1.74%)
Volume
  1,048,382
Open
 17.75
High
 18.11
Low
 17.14
8EMA (Daily)
 17.55
40EMA (Daily)
 16.65
50EMA (Daily)
 16.38
STO (Daily)
 85.147
MACD Hist (Daily)
 0.192
8EMA (Weekly)
 17.013
40EMA (Weekly)
 14.90
50EMA (Weekly)
 14.55
STO (Weekly)
 82.508
MACD Hist (Weekly)
 0.226
Axogen Inc is engaged in the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically proven and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, United Kingdom, Spain, South Korea, and several other countries.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com